Accession Number:



Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy and Improve Functional Outcomes Following Peripheral Nerve Injury and Repair

Descriptive Note:

[Technical Report, Annual Report]

Corporate Author:

Johns Hopkins University

Personal Author(s):

Report Date:


Pagination or Media Count:



We are currently completing the set-up phase for this study. We have hired and trained all necessary staff. We have finalized drug distribution plans with Theratechnologies and the JHH research pharmacy. We have finalized our data management plan with REDCap and our biostatistician. We have received IRB approval from JHU IRB and IRB waivers from our primary recruitment sites Union Memorial Hospital and University of Maryland Medical CenterShock Trauma. The final step with regards to study set up prior to beginning recruitment will be to receive HRPO approval.


Subject Categories:

  • Anatomy and Physiology
  • Medicine and Medical Research

Distribution Statement:

[A, Approved For Public Release]